New drug-pricing plan aims to improve transparency in pharmaceutical industry

As a long-term plan to improve the transparency of the domestic pharmacy industry, the government plans to offer financial incentives to drug makers who invest more on research and development, said an official at the Ministry for Health, Welfare and Family Affairs.

In a recent press interview, the ministry official Kim Sang-hee said that when locally developed drugs are approved by drug age...